Aurora Cannabis (TSX:ACB) Just Won a Huge Supply Contract That Could Change Everything

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) won a huge Italian supply contract that could solidify its place as the leading weed exporter.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) is a cannabis export powerhouse. Shipping weed everywhere from Germany to the U.K., it has become a truly international company.

Currently, Aurora’s international operations reach 24 countries, and with 40 nations in total having legalized medical pot, that reach could get even wider.

Recently, Aurora’s international operations got a big boost when it was announced that the company had won a tender to supply 400 kilograms of cannabis to Italy over the course of two years.

As the sole winner of the contract, Aurora will have a dominant position in Italy’s emerging cannabis market. This bears well for Aurora’s future, as it shows that the company is establishing a strong position in one of the world’s fastest-growing cannabis markets.

Why the European market matters so much

As Sean Williams reported in a recent fool.com piece, 40 countries worldwide have legalized medical cannabis, with a significant number of those are in Europe. Medical marijuana is a booming business in Germany, the U.K. and Denmark, with many more EU countries soon to follow.

As medical pot is so widely accepted in Europe, the continent has become one of the most lucrative cannabis markets in the world: according to consultancy.eu, the cannabis market in the region is worth €16.6 billion a year.

This means that the more a Canadian company expands into EU markets, the greater its potential revenue growth.

Illegal pot gets cheaper while legal weed gets more expensive

A massive accessible market isn’t the only reason why the EU is so important to Canadian pot producers — a relative lack of growth potential at home is another.

Although the Canadian marijuana market was bolstered by the legalization of adult-use sales last October, there are signs that the recreational weed market has already peaked.

In a recent quarter, Aphria saw its recreational sales decline 35%, while Aurora’s recreational sales growth was tepid compared to international medical sales growth.

One of the reasons for this is the fact that black market pot keeps getting cheaper, while the legal stuff becomes more expensive. According to a recent StatsCan report, street prices have fallen from $6.23 to $5.93 per gram, while in-store prices have risen from $10.21 to $10.65.

This means that black market cannabis is far more affordable than the legal equivalent, providing customers with a strong incentive to choose dealers over stores.

Foolish takeaway

Aurora Cannabis has long been one of the largest and fastest-growing weed companies. With its massive international presence and a huge share of the domestic adult-use market, it’s a juggernaut in every sense of the word.

Now, with an exclusive Italian supply deal in place, it’s ready to move 400 kilograms worth of weed in one of the EU’s most lucrative markets. If there was ever a good time to consider investing in Aurora over its competitors, now would be it.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »